68.42
Schlusskurs vom Vortag:
$67.68
Offen:
$67.39
24-Stunden-Volumen:
221.38K
Relative Volume:
0.12
Marktkapitalisierung:
$6.13B
Einnahmen:
$288.07M
Nettoeinkommen (Verlust:
$22.31M
KGV:
483.23
EPS:
0.1416
Netto-Cashflow:
$41.15M
1W Leistung:
-1.86%
1M Leistung:
-24.20%
6M Leistung:
+90.65%
1J Leistung:
+146.00%
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LQDA
Liquidia Corp
|
68.49 | 6.06B | 288.07M | 22.31M | 41.15M | 0.1416 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.29 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.88 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.165 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.52 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
497.22 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
LIQUIDIA CORP (NASDAQ:LQDA) Fits the Affordable Growth Screen - ChartMill
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com India
Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp Stock Intrinsic Values - GuruFocus
Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)? - Yahoo Finance
Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation? - Yahoo Finance
Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks - Yahoo Finance
Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com
Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media
How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media
Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance
LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus
Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative
Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan
Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus
Two lung-disease studies will be presented in Barcelona - Stock Titan
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - The Manila Times
Liquidia Corp Stock Operating Data - GuruFocus
Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition? - Yahoo Finance
Q1 2025 Liquidia Corp Earnings Call Transcript - GuruFocus
Liquidia Corp (HAM:LT4) Valuation: Possible Value Trap, Think Twice - GuruFocus
Liquidia Corp (HAM:LT4)Valuation Measures & Financial Statistics - GuruFocus
HAM:LT4 Dividend: Does Liquidia Corp Pay a Dividend? - GuruFocus
Who's Buying or Selling Liquidia Corp (HAM:LT4) Stock Today? - GuruFocus
Liquidia Corp (HAM:LT4) Stock Price & 30 Year Financial Data - GuruFocus
Liquidia Corp (HAM:LT4) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Liquidia Corp (HAM:LT4) Competitors 2026 - GuruFocus
Bank of New York Mellon Corp Makes New Investment in Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp (LQDA) Stock Down 3.1% -- Now Undervalued? GF Scor - GuruFocus
Liquidia Corporation $LQDA Shares Bought by Seven Fleet Capital Management LP - MarketBeat
Liquidia Slips as Post-Earnings Selling Continues - Quiver Quantitative
Liquidia (NASDAQ:LQDA) Director Katherine Rielly-Gauvin Sells 36,789 Shares of Stock - MarketBeat
Insider at Liquidia (NASDAQ: LQDA) plans multimillion-dollar stock sale - Stock Titan
Liquidia (NASDAQ: LQDA) director sells 55K shares in 10b5-1 trades - Stock Titan
Liquidia Corp (LQDA) Shares Fall 5.8% -- What GF Score of 70 Tel - GuruFocus
Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat - Stocktwits
Liquidia Corp (LQDA) CMO cashes in options, unloads 79K+ shares - Stock Titan
Liquidia (NASDAQ: LQDA) director to sell shares after option exercises - Stock Titan
Liquidia (NASDAQ: LQDA) officer eyes $3.7M Rule 144 stock resale - Stock Titan
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion? - Zacks Investment Research
Renaissance Technologies LLC Sells 198,753 Shares of Liquidia Corporation $LQDA - MarketBeat
A Look at Liquidia Corp (LQDA) After 4.3% Gain -- GF Value $267. - GuruFocus
Liquidia (NASDAQ: LQDA) affiliate plans new stock sale after $710K July trade - Stock Titan
LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now? - Yahoo Finance
Greenhaven Road Capital: Short Term Gain Realized from Liquidia (LQDA), Investment to Be Revisited - Yahoo Finance
Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Zacks Research - MarketBeat
Teleconferência de Resultados do 2T26 da Liquidia (LQDA): Vendas do YUTREPIA Crescem 31% - TradingKey
Liquidia Corp (LQDA) sees 6.5% stake reported by investor Paul B. Manning - Stock Titan
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Adair Jason | Chief Business Officer |
Aug 21 '26 |
Sale |
69.09 |
73,631 |
5,087,225 |
174,606 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):